Free Trial

Integra LifeSciences (IART) Competitors

Integra LifeSciences logo
$15.13 -0.03 (-0.20%)
Closing price 09/3/2025 04:00 PM Eastern
Extended Trading
$15.14 +0.01 (+0.07%)
As of 09/3/2025 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IART vs. ITGR, ATEC, ATRC, OFIX, SRDX, ANGO, ARAY, RMTI, RSLS, and ABT

Should you be buying Integra LifeSciences stock or one of its competitors? The main competitors of Integra LifeSciences include Integer (ITGR), Alphatec (ATEC), AtriCure (ATRC), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), and Abbott Laboratories (ABT). These companies are all part of the "health care equipment" industry.

Integra LifeSciences vs. Its Competitors

Integra LifeSciences (NASDAQ:IART) and Integer (NYSE:ITGR) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, media sentiment, earnings, risk, dividends, profitability and institutional ownership.

In the previous week, Integer had 3 more articles in the media than Integra LifeSciences. MarketBeat recorded 11 mentions for Integer and 8 mentions for Integra LifeSciences. Integer's average media sentiment score of 1.19 beat Integra LifeSciences' score of 1.03 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integra LifeSciences
5 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
9 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integra LifeSciences currently has a consensus price target of $18.43, suggesting a potential upside of 21.80%. Integer has a consensus price target of $140.25, suggesting a potential upside of 32.64%. Given Integer's stronger consensus rating and higher probable upside, analysts plainly believe Integer is more favorable than Integra LifeSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integra LifeSciences
4 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
1.78
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Integer has higher revenue and earnings than Integra LifeSciences. Integra LifeSciences is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integra LifeSciences$1.61B0.73-$6.94M-$6.53-2.32
Integer$1.72B2.16$119.90M$2.2746.58

Integer has a net margin of 4.61% compared to Integra LifeSciences' net margin of -30.87%. Integer's return on equity of 12.27% beat Integra LifeSciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Integra LifeSciences-30.87% 12.15% 4.32%
Integer 4.61%12.27%6.23%

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 3.5% of Integra LifeSciences shares are owned by insiders. Comparatively, 2.2% of Integer shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Integra LifeSciences has a beta of 1.2, meaning that its share price is 20% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.

Summary

Integer beats Integra LifeSciences on 15 of the 17 factors compared between the two stocks.

Get Integra LifeSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IART and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IART vs. The Competition

MetricIntegra LifeSciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$1.18B$7.08B$5.77B$9.76B
Dividend YieldN/A1.19%6.66%4.49%
P/E Ratio-2.3225.2882.3726.60
Price / Sales0.7371.18525.54161.29
Price / Cash3.4022.4425.7028.92
Price / Book1.146.9510.646.56
Net Income-$6.94M$176.68M$3.28B$266.04M
7 Day Performance1.95%-0.54%0.10%-0.89%
1 Month Performance20.46%2.05%8.91%4.34%
1 Year Performance-21.73%10.03%48.38%24.06%

Integra LifeSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IART
Integra LifeSciences
3.3675 of 5 stars
$15.13
-0.2%
$18.43
+21.8%
-21.5%$1.18B$1.61B-2.324,396News Coverage
Positive News
ITGR
Integer
4.175 of 5 stars
$108.98
-1.4%
$140.25
+28.7%
-16.7%$3.87B$1.72B48.0111,000Positive News
ATEC
Alphatec
3.999 of 5 stars
$15.84
-1.9%
$18.50
+16.8%
+133.8%$2.39B$611.56M-14.02700Positive News
ATRC
AtriCure
3.7536 of 5 stars
$37.84
+0.5%
$50.89
+34.5%
+34.0%$1.87B$465.31M-49.141,300News Coverage
Positive News
OFIX
Orthofix Medical
3.1945 of 5 stars
$14.50
-0.3%
$21.50
+48.3%
-11.8%$574.64M$799.49M-4.571,616Positive News
SRDX
Surmodics
4.4425 of 5 stars
$35.31
-5.1%
$43.00
+21.8%
-13.2%$531.73M$126.08M-28.71450Positive News
ANGO
AngioDynamics
4.2615 of 5 stars
$9.68
+2.4%
$19.00
+96.3%
+45.1%$383.99M$292.50M-11.66760News Coverage
Positive News
ARAY
Accuray
4.6717 of 5 stars
$1.55
-2.5%
$5.00
+222.6%
-30.8%$179.10M$458.51M-77.501,040
RMTI
Rockwell Medical
3.8346 of 5 stars
$1.30
+14.0%
$4.00
+207.7%
-46.6%$39.25M$101.49M-21.67300Short Interest ↑
High Trading Volume
RSLS
ReShape Lifesciences
0.1703 of 5 stars
$3.16
-1.4%
N/A-99.6%$8.49M$8.01M-0.0350Positive News
Gap Down
High Trading Volume
ABT
Abbott Laboratories
4.9315 of 5 stars
$132.02
-0.4%
$144.47
+9.4%
+15.1%$230.77B$41.95B16.54114,000Positive News

Related Companies and Tools


This page (NASDAQ:IART) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners